{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":24,"n_cols":5,"rows_kept":24,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[10,2,10,3],[11,2,11,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910827377003321"]
[null,null,"Titolo",null,"Cannabis Law : A Primer on Federal and State Law Regarding Marijuana, Hemp, and CBD / / edited by Barak Cohe and Michael C. Bleicher"]
[null,null,"Pubbl/distr/stampa",null,"Chicago, Illinois : , : American Bar Association, , [2021]"]
[{"$nulls":4},"©2021"]
[null,null,"ISBN",null,"1-64105-827-7"]
[null,null,"Descrizione fisica",null,"1 online resource (256 pages)"]
[null,null,"Disciplina",null,"343.73076353"]
[null,null,"Soggetti",null,"Marijuana - Law and legislation - United States"]
[{"$nulls":4},"Marijuana industry - Law and legislation - United States"]
[{"$nulls":4},"Marijuana - Law and legislation - United States - States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Includes index."]
[null,null,"Nota di contenuto",null,"Intro -- Title Page -- Copyright Page -- Contents -- Editor's Note -- Preface -- Acknowledgments -- Chapter 1 : Basic Issues: The Tension between Federal and State Law and Policy -- 1. Introduction -- 2. Definitions -- 3. Overview of Law and Regulation -- 3.1 Federal Law and Enforcing Agencies -- 3.1.1 U.S. Congress and DOJ -- 3.1.2 U.S. Food and Drug Administration (FDA) -- 3.1.3 Federal Trade Commission (FTC) -- 3.1.4 U.S. Department of Agriculture (USDA) -- 3.1.5 U.S. Department of Treasury (Treasury) -- 4. Cannabis and Hemp: Enforcement -- 4.1 DOJ -- 4.2 FDA and FTC -- 4.3 Treasury -- 5. Proposed and Pending Federal Legislation -- 5.1 Decriminalization -- 5.2 Banking -- 5.3 Looking Forward -- 6. States -- 7. Afterword -- Chapter 2 : Transactional Considerations -- 1. Introduction -- 2. Private Company Transactions -- 2.1 Federal Legal Considerations -- 2.2 State Regulatory Considerations -- 2.2.1 Transfers of Applicable Licenses -- 2.2.2 Restrictions on Ownership of Cannabis Businesses -- 2.2.3 Reporting Requirements for Owners of Cannabis Businesses -- 2.3 Contract Considerations -- 2.3.1 Structure -- 2.3.2 Representations, Warranties, and Indemnification -- 2.3.3 Covenants and Conditions -- 2.3.4 Dispute Resolution -- 2.3.5 Minority Investments and Joint Ventures -- 3. Public Company Transactions -- 3.1 Disclosure Requirements -- 3.2 Exchange Rules -- Chapter 3 : Banking and Finance Issues -- 1. Introduction -- 2. Federal Controlled Substances Act -- 3. Dual-Banking System -- 4. Bank Secrecy Act and "]
[{"$nulls":4},"Anti-Money Laundering Laws -- 4.1 Asset Forfeiture -- 4.2 Fines and Imprisonment -- 4.3 Bank Regulator Oversight -- 4.4 BSA Requirements -- 4.4.1 Establish Written Internal Policies, Procedures, and Controls -- 4.4.2 Conduct Independent Testing -- 4.4.3 Designate a BSA/AML Compliance Officer."]
[{"$nulls":4},"4.4.4 Provide Ongoing Training to Relevant Employees -- 4.4.5 Customer Due Diligence -- 5. Suspicious Activity Report Filing -- 5.1 Hemp Business and SARs -- 6. Currency Transaction Reporting -- 7. Federal Legislation -- 8. State Marijuana Banking Innovations -- 9. Identifying a Bank for MRBs -- 10. Payments for Marijuana -- Chapter 4 : Employment -- 1. Federal Law Grants Employers Greater Rights to Regulate Cannabis in the Workplace -- 2. Cannabis and the Hiring Process -- 2.1 Background Checks and Consideration of Cannabis-Related Arrests and Convictions in Hiring Decisions -- 2.2 Pre-Employment Drug Testing -- 2.3 Consideration of an Applicant's Participation in a Medical Cannabis Program or an Applicant's Off-Duty Use of Cannabis -- 3. Cannabis Use during Employment -- 3.1 On-Duty Use or Possession of Cannabis Products -- 3.2 Off-Duty Use of Cannabis Products -- 3.3 Post-Hiring Drug Testing for Cannabis Use -- 3.4 Accommodating Cannabis Use -- 3.4.1 Accommodating Cannabis Use under the Americans with Disabilities Act -- 3.4.2 Accommodating Medical Cannabis Use under State Law -- 3.4.3 Accommodating Recreational Cannabis Use under State Law -- 4. Carve-Outs from State Cannabis Laws -- 4.1 Safety-Sensitive Positions -- 4.2 Exception for Compliance with Federal Law, Contracts, Funding, or Licensing Requirements -- 4.3 Job Positions Regulated by Federal Agencies -- 5. Related Topics Associated with Cannabis Use and Employment -- 5.1 Workers' Compensation Benefits -- 5.2 Unemployment Benefits -- Chapter 5 : Cannabis and Real Property -- 1. Acquisition of Real Property for Cannabis-Related Uses -- 1.1 Real Estate Broker Issues -- 1.2 Financing Issues -- 1.2.1 Investors -- 1.2.2 Banks and Other Financial Institutions -- 1.2.3 Hemp and Hemp Derivatives -- 1.3 Title Insurance Issues and Real Estate Due Diligence -- 1.4 Property Insurance."]
[{"$nulls":4},"2. Commercial Leasing for Cannabis-Related Uses -- 2.1 Leasing Due Diligence and Loan Document Review -- 2.2 Enforcement Issues -- 2.3 Drafting Considerations -- 2.3.1 License Contingency or Condition Subsequent Clause -- 2.3.2 Permitted Use -- 2.3.3 Applicable Laws/Compliance with Laws -- 2.3.4 Rent and Form of Payment -- 2.3.5 Security and On-Site Cash -- 2.3.6 Landlord's Access -- 2.3.7 Tenant Improvements -- 2.3.8 Common Areas/Odors/Etc -- 2.3.9 Utilities and Operating Expenses -- 2.3.10 Environmental Concerns -- 2.3.11 Insurance and Indemnification -- 2.3.12 Surrender and Other End-of-Term Provisions -- 3. Forfeiture -- 4. Use Restrictions -- 5. Conclusion -- Chapter 6 : Tax Law Issues -- 1. Federal Income Tax Issues -- 1.1 General Principles -- 1.2 Internal Revenue Code Section 280E-Operating Expenses Not Deductible -- 1.2.1 \"Trafficking\" -- 1.2.2 \"Controlled Substances\" -- 1.2.3 Application to Non-Cannabis Lines of Business -- 1.2.4 Application to Internal Revenue Code Section 199A -- 1.2.5 Constitutional Issues-Eighth Amendment -- 1.2.6 Constitutional Issues-Fifth Amendment -- 1.2.7 Constitutional Issues-Sixteenth Amendment -- 1.3 Reductions to Gross Income-Internal Revenue Code Section 471 (Cost of Goods Sold) -- 1.3.1 Resellers -- 1.3.2 Producers -- 1.4 Reductions to Gross Income-Internal Revenue Code Section 164 (Taxes) -- 1.5 Internal Revenue Code Section 501(c)-Exempt Organizations -- 2. State Tax Issues -- 2.1 Income Taxes -- 2.1.1 California -- 2.1.2 Colorado -- 2.1.3 Illinois -- 2.1.4 Oregon -- 2.2 Other General Business Activity Taxes -- 2.3 General Retail Sales "]
[{"$nulls":4},"Taxes -- 2.3.1 \"Sales\" -- 2.3.2 Exemptions -- 2.3.3 Business Inputs Exemptions or Incentives -- 2.4 Cannabis Excise Taxes -- 2.4.1 Weight-Based Excise Taxes -- 2.4.2 Price-Based Excise Taxes -- 2.4.3 Stamp Taxes -- 2.5 Non-Marijuana Forms of Cannabis (Hemp and CBD)."]
[{"$nulls":4},"Chapter 7 : Marketing -- 1. Marketing Cannabis Products in the United States -- 1.1 Cannabis, Marijuana, and Hemp -- 1.2 Cannabis Derivatives -- 1.3 Legality of Advertising Cannabis Products -- 2. Regulatory Framework for Hemp and Hemp Derivative Advertising -- 2.1 Federal Advertising Laws -- 2.1.1 FTC -- 2.1.2 Lanham Act -- 2.1.3 Federal Food, Drug, Dietary Supplements, and Cosmetics Regulation -- 2.2 State Laws -- 2.2.1 Mini-FTC Acts and Consumer Protection Laws -- 2.2.2 State Hemp and Hemp Derivative Laws -- 2.3 National Advertising Division -- 3. Advertising Basics -- 3.1 Identifying an Advertising Claim -- 3.2 Puffery -- 3.3 Disclosures -- 3.4 Substantiating Advertisement Claims -- 3.4.1 Generally -- 3.4.2 Scientific Claims -- 3.5 Health Claims -- 3.5.1 Generally -- 3.5.2 Examples of Prohibited Health Claims -- 3.6 Advertising Issues Regulated by the FDA -- 3.6.1 Drug Advertising -- 3.6.2 Dietary Supplement Advertising -- 3.6.3 Food Product Advertising -- 3.6.4 Cosmetic Advertising -- 3.6.5 Unapproved New Animal Products -- 4. Special Advertising Issues -- 4.1 Endorsements and Testimonials -- 4.2 Comparative Advertising -- 4.3 Price Advertising -- 4.4 Contest and Sweepstakes Promotions -- 5. Marijuana and Marijuana Derivative Advertising -- 5.1 Federal Law -- 5.2 State Laws -- 6. Conclusion -- Chapter 8 : Trademarks -- 1. Federal Overview of Cannabis Trademarks -- 1.1 The Federal Lanham Act and the Lawful Use in Commerce Requirement -- 1.2 Compliance with the Controlled Substances Act -- 1.3 The 2018 Farm Bill and Examination Guide 1-19 -- 2. Alternative Trademark Protection for the Cannabis Industry and Its Limitations -- 2.1 State Trademark Registrations -- 2.2 Federal Registration for Ancillary Goods or Services -- 3. Trademark Infringement and Dilution -- 3.1 Likelihood of Confusion -- 3.2 Dilution by Tarnishment -- 4. Takeaways."]
[{"$nulls":4},"Chapter 9 : Patent Law in the Cannabis Industry -- 1. Introduction -- 2. How Can the Industry Protect Its IP? -- 2.1 Utility Patents -- 2.2 Design Patents -- 2.3 Plant Patents -- 2.4 Plant Variety Certifications -- 3. Why Is Patentability Important? -- 3.1 Marketability for Future Consolidation -- 3.2 Enforceability in the Courts -- 3.3 Potential for Patent Challenges via Inter Partes Review -- 4. Conclusion -- Chapter 10 : Cannabis Litigation: Trends and Considerations -- 1. Cannabis and Civil Litigation -- 1.1 Types of Cases -- 1.1.1 Consumer Protection -- 1.1.2 Products Liability and Negligence -- 1.1.3 California Proposition -- 1.1.4 Contract Law -- 1.1.5 Class Actions -- 1.2 Common Defenses -- 1.2.1 Pleading with Specificity -- 1.2.2 Reasonable Consumer -- 1.3 Preemption -- 1.4 Primary Jurisdiction -- 2. Conclusion -- Chapter 11 : Insurance Considerations for the Cannabis Industry -- 1. Overview of Basic Insurance Products -- 1.1 Comprehensive General Liability -- 1.2 Property Loss and Business Interruption Insurance -- 1.3 Commercial Crime or Fidelity Insurance -- 1.4 Cyber Insurance -- 1.4.1 Network Security -- 1.4.2 Privacy -- 1.4.3 Business Interruption -- 1.4.4 Directors and Officers (D&amp -- O) Liability -- 2. Overview of Key Risks and the Corresponding Insurance Product -- 2.1 Product Liability -- 2.2 Fires, Bugs, and Other Sources of Property Loss -- 2.3 Theft -- 2.4 Improper Release of Customer Information -- 2.5 Loss of Share Value -- 3. Judicial Guidance -- 4. Conclusion -- Chapter 12 : Bankruptcy -- 1. Introduction to Bankruptcy, Receiverships, and Assignments for the Benefit of Creditors -- 2. Treatment of Cannabis in "]
[{"$nulls":4},"Bankruptcy Cases -- 3. Treatment of Cannabis in Receiverships and ABCs -- 3.1 Receiverships -- 3.2 ABCs -- Chapter 13 : Regulation of Cannabis-Containing Products in the U.S. Food and Beverage Supply."]
[{"$nulls":4},"1. Federal Food Safety Oversight."]
[null,null,null,"Sommario/riassunto","Until now, there has been no single reference to guide cannabis lawyers along the full continuum of potential legal needs challenging the industry. This treatise fills that gap from a sophisticated perspective by flagging key issues in more than a dozen practice areas and covering the impact of cannabis law from U.S. state and federal, as well as Canadian, enforcement and regulatory agencies."]